Magwenzi S. CRP Predicts Biochemical but Not Clinical Remission in Ustekinumab-Treated Crohn’s Disease: A Remission-Specific Whole-Blood Transcriptomic Signature: Transcriptomic biomarkers for ustekinumab response in Crohn’s disease. J. Precis. Med. Artif. Intell. [Internet]. 2026 Jun. 9 [cited 2026 Jun. 17];1(1). Available from: https://jpmedai.com/index.php/jpmedai/article/view/11